Literature DB >> 24743615

Postoperative transitional care needs in the elderly: an outcome of recovery associated with worse long-term survival.

Linda T Li1, Gala M Barden, Courtney J Balentine, Sonia T Orcutt, Aanand D Naik, Avo Artinyan, Shubhada Sansgiry, Daniel Albo, David H Berger, Daniel A Anaya.   

Abstract

OBJECTIVE: To characterize transitional care needs (TCNs) after colorectal cancer (CRC) surgery and examine their association with age and impact on overall survival (OS).
BACKGROUND: TCNs after cancer surgery represent additional burden for patients and are associated with higher short-term mortality. They are not well-characterized in CRC patients, particularly in the context of a growing elderly population, and their effect on long-term survival is unknown.
METHODS: A retrospective cohort study of CRC patients (N = 486) having curative surgery at a tertiary referral center (2002-2011) was conducted. Outcomes included TCNs (home health or nonhome destination at discharge) and OS. Patients were compared on the basis of age: young (<65 years), old (65-74 years), and oldest (≥75 years). Multivariate logistic regression models were used to examine the association of age with TCNs, and OS was compared on the basis of TCNs and stage, using the Kaplan-Meier method.
RESULTS: TCNs were required by 130 patients (27%). The oldest patients had highest TCNs (49%) compared with the other age groups (P < 0.01), with rehabilitation services as their primary TCNs (80%). After multivariate analysis, patients 75 years or older had significantly increased TCN risk (odds ratio, 4.7; 95% confidence interval, 2.6-8.5). TCN was associated with worse OS for patients with early- and advanced stage CRC (P < 0.001).
CONCLUSIONS: TCNs after CRC surgery are common and significantly increased in patients 75 years or older, represent an outcome of postoperative recovery, and are associated with worse long-term survival. Preoperative identification of higher risk populations should be used for patient counseling, advanced preoperative planning, and to implement strategies targeted at minimizing TCNs.

Entities:  

Mesh:

Year:  2015        PMID: 24743615     DOI: 10.1097/SLA.0000000000000673

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Factors related to readmission after major elective surgery.

Authors:  Gregory C Wilson; R Cutler Quillin; Jeffrey M Sutton; Koffi Wima; Joshua J Shaw; Richard S Hoehn; Ian M Paquette; Daniel E Abbott; Shimul A Shah
Journal:  Dig Dis Sci       Date:  2014-07-27       Impact factor: 3.199

2.  Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy.

Authors:  Katelyn F Flick; C Max Schmidt; Cameron L Colgate; Michele T Yip-Schneider; Chris M Sublette; Thomas K Maatman; Mazhar Soufi; Eugene P Ceppa; Michael G House; Nicholas J Zyromski; Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2020-06-24       Impact factor: 3.452

3.  A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.

Authors:  H S Richards; J M Blazeby; A Portal; R Harding; T Reed; T Lander; K A Chalmers; R Carter; R Singhal; K Absolom; G Velikova; K N L Avery
Journal:  BMC Cancer       Date:  2020-06-10       Impact factor: 4.430

4.  Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.

Authors:  Kerry N L Avery; Hollie S Richards; Amanda Portal; Trudy Reed; Ruth Harding; Robert Carter; Leon Bamforth; Kate Absolom; Elaine O'Connell Francischetto; Galina Velikova; Jane M Blazeby
Journal:  BMC Cancer       Date:  2019-05-17       Impact factor: 4.430

5.  Patient experiences of an electronic PRO tailored feedback system for symptom management following upper gastrointestinal cancer surgery.

Authors:  H S Richards; A Portal; K Absolom; J M Blazeby; G Velikova; K N L Avery
Journal:  Qual Life Res       Date:  2020-06-13       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.